Viewing nowCosca Tablet 50 mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

MFDS item code 200803975 · Notified 2008.04.11 · Insurance code 644702820
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus and hypertension
This medication is used to treat hypertension. It is also helpful in treating nephropathy in patients with type 2 diabetes and hypertension. This drug helps control blood pressure, reducing the risk of cardiovascular complications and contributing to the protection of kidney function. It improves various symptoms associated with hypertension, enhancing overall health.
This drug may be taken with or without food, but it is recommended to take it at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is seen 3 ∼ 6 weeks after starting treatment. If the response is inadequate, the same dose may be given orally in two divided doses per day, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this drug alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered with insulin and commonly used hypoglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years or older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily; the dose may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily; the dose may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This drug may cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, and should be discontinued immediately upon confirmation of pregnancy. It is safest for women who may become pregnant to avoid using this drug. Patients with an allergy to this medication, severe liver dysfunction, or specific genetic lactose metabolism disorders should not take it. Elderly patients, those with impaired kidney function, very low blood pressure, or heart valve issues should take this medication under careful medical supervision. This drug may cause hyperkalemia, so patients with high potassium levels or those taking potassium supplements should be particularly cautious. If blood pressure drops too low, symptoms such as dizziness or fainting may occur, and any symptoms should be reported to a healthcare professional immediately. Rarely, serious side effects such as angioedema, hepatitis, renal failure, and skin rashes may occur, so any abnormal symptoms should be discussed with a specialist immediately. When taking this medication alongside other antihypertensives, diuretics, or non-steroidal anti-inflammatory drugs (NSAIDs), interactions may occur, so it is essential to inform your healthcare provider. Regular monitoring of blood pressure, blood tests, and kidney function tests is necessary during treatment, especially for women who are pregnant or planning pregnancy, who should consult their doctor before use. It is not recommended for children under 6 years of age, as safety and efficacy have not been established. This medication should be stored out of reach of children and in its original container without transferring to another.
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it should be kept in a tightly sealed container. It is advisable to maintain storage temperatures between 1 to 30 degrees Celsius. Proper storage will ensure the safety and efficacy of the medication.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.